Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
11/2012
11/01/2012WO2012147901A1 Composition for mitigating anticancer drug side effects
11/01/2012WO2012147834A1 Radiation sensitizing agent
11/01/2012WO2012147831A1 Method for manufacturing phosphonocrotonic acid derivative
11/01/2012WO2012147713A1 Anti-b7-h3 antibody
11/01/2012WO2012146936A1 Pyrrolnitrin derivatives
11/01/2012WO2012146933A1 Cyprodinil for use in medicine
11/01/2012WO2012146890A1 Prebiotic agent
11/01/2012WO2012146800A1 Use of diterpenoid compounds as antiinflammatory and antitumour agents
11/01/2012WO2012146706A1 Methods and pharmaceutical compositions for the treatment of hormone-refractory prostate cancers
11/01/2012WO2012146702A1 Methods for preparing accessory cells and uses thereof for preparing activated nk cells
11/01/2012WO2012146667A1 Imidazopyridine derivatives as pi3k inhibitors
11/01/2012WO2012146666A1 Pyrrolotriazinone derivatives as pi3k inhibitors
11/01/2012WO2012146625A1 Lyophilized preparation of cytotoxic dipeptides
11/01/2012WO2012146610A1 Composition comprising aflibercept, folinic acid, 5-fluorouracil (5-fu) and irinocetan (folfiri)
11/01/2012WO2012146394A1 Dosage regimen for administering a cd19xcd3 bispecific antibody to patients at risk for potential adverse effects
11/01/2012WO2012146057A1 Curcuminoid injection solution and intravenous injection
11/01/2012WO2012145981A1 Adamantane or adamantane-like compounds as antitumor agents
11/01/2012WO2012145908A1 P21 and p21-associated molecules as biomarkers
11/01/2012WO2012145890A1 Use of regulator of calcineurin 1 for manufacturing medicament for treatment of diseases associated with increased nf-κb activity
11/01/2012WO2012145801A1 Nanoparticle
11/01/2012WO2012115446A3 Compound based on 5-(substituted alkyl-aminomethyl) isoxazole acting as a t-type calcium channel antagonist
11/01/2012WO2012109238A3 Methods for increasing immune responses using agents that directly bind to and activate ire-1
11/01/2012WO2012106473A3 Dosing for treatment with anti-egfl7 antibodies
11/01/2012WO2012103456A3 Polycyclic beta lactam derivatives for the treatment of cancer
11/01/2012WO2012100045A9 Methods of predicting response to jnk inhibitor therapy
11/01/2012WO2012097133A3 Compounds and methods for inducing apoptosis in cancer cells using a bh3 alpha-helical mimetic
11/01/2012WO2012094574A3 Stabilized polyribonucleotide nanoparticles
11/01/2012WO2012075340A3 Anti-ngf compositions and use thereof
11/01/2012WO2012066581A4 Novel conjugates for targeted drug delivery
11/01/2012WO2007049041A8 4- (3-aminopyrazole) pyrimidine derivatives for use as tyrosine kinase inhibitors in the treatment of cancer
11/01/2012US20120277517 Formulation and Methods for Enhanced Interventional Image-Guided Therapy of Cancer
11/01/2012US20120277320 Inhibition of the survival of skin cancer by cyclohexenone compounds from antrodia camphorata
11/01/2012US20120277308 compounds for treating cancer and other diseases
11/01/2012US20120277303 Equol-containing fermentation product of soybean embryonic axis, and method for production thereof
11/01/2012US20120277301 Chroman-derived anti-androgens for treatment of androgen mediated disorders
11/01/2012US20120277295 Kit for cancer treatment and pharmaceutical composition for cancer treatment
11/01/2012US20120277289 Activity generating delivery molecules
11/01/2012US20120277287 Modulating the CDC14B-CDH1-PLK1 Axis and Methods for Sensitizing Target Cells to Apoptosis
11/01/2012US20120277284 Modulation of signal transducer and activator of transcription 3 (stat3)expression
11/01/2012US20120277283 Localized Delivery of Gold Nanoparticles for Therapeutic and Diagnostic Applications
11/01/2012US20120277281 Polynucleotides for medical use
11/01/2012US20120277280 Phenoxy-pyrrolidine derivative and its use and compositions
11/01/2012US20120277279 Non-Steroidal Glucocorticoid Inhibitors and Their Use in Treating Inflammation, Allergy and Auto-Immune Conditions
11/01/2012US20120277277 Methods of Treating a Hyperproliferative Disorder or Inhibiting Cell Growth in a Mammal
11/01/2012US20120277274 Epothilone compound formulations
11/01/2012US20120277258 Chemical Compounds
11/01/2012US20120277257 Methods of Treating Diseases, Pharmaceutical Compositions, and Pharmaceutical Dosage Forms
11/01/2012US20120277256 Frequency modulated drug delivery (fmdd)
11/01/2012US20120277255 Inhibitors of bruton's tyrosine kinase
11/01/2012US20120277254 Inhibitors of bruton's tyrosine kinase
11/01/2012US20120277251 Analogs of dehydrophenylahistins and their therapeutic use
11/01/2012US20120277248 Substituted pyrrolo-pyrazole derivatives as kinase inhibitors
11/01/2012US20120277247 Novel compound useful for the treatment of degenerative and inflammatory diseases
11/01/2012US20120277246 Use of N-Phenyl-2-pyrimidineamine Derivatives Against Mast Cell-based Diseases Like Allergic Disorders
11/01/2012US20120277245 Method of Increasing Intratumoral pHe and Reducing Acid-Mediated Invasion
11/01/2012US20120277240 Substituted aminotetrahydrothiopyrans and derivatives thereof as dipeptidyl peptidase-iv inhibitors for the treatment of diabetes
11/01/2012US20120277236 Method for inhibiting mmp-9 dimerization
11/01/2012US20120277233 Pyridyl-Triazine Inhibitors of Hedgehog Signaling
11/01/2012US20120277231 Quinolinyloxyphenylsulfonamides
11/01/2012US20120277230 Compounds useful for treating cancer
11/01/2012US20120277229 Substituted 3-(1h-benzo[d]imidazol-2-yl)-1h-indazole analogs as inhibitors of the pdk1 kinase
11/01/2012US20120277228 Novel Azaheterocyclic Compounds
11/01/2012US20120277227 Benzimidazole inhibitors of leukotriene production
11/01/2012US20120277226 Benzimidazole inhibitors of leukotriene production
11/01/2012US20120277225 Inhibitors of bruton's tyrosine kinase
11/01/2012US20120277224 Heterocyclic compounds for the inhibition of pask
11/01/2012US20120277219 Novel pyridopyrazine derivatives, process of manufacturing and uses thereof
11/01/2012US20120277215 Organic Compounds
11/01/2012US20120277214 Tricyclopyrazole derivatives
11/01/2012US20120277212 Novel Oxime Derivatives and Their Use As Allosteric Modulators of Metabotropic Glutamate Receptors
11/01/2012US20120277210 Solid dispersions containing an apoptosis-inducing agent
11/01/2012US20120277199 Modulation of Gel Temperature of Poloxamer-Containing Formulations
11/01/2012US20120277198 Polyhydroxylated bile acids for treatment of biliary disorders
11/01/2012US20120277196 Natural marine source phospholipids comprising polyunsaturated fatty acids and their applications
11/01/2012US20120277192 Aminopyrimidines as syk inhibitors
11/01/2012US20120277176 Protein Arginine Deiminase Inhibitors as Novel Therapeutics for Rheumatoid Arthritis and Cancer
11/01/2012US20120277174 New macrolides and their use
11/01/2012US20120277169 Nyasol and analogs thereof for the treatment of estrogen receptor beta-mediated diseases
11/01/2012US20120277164 Gadd45beta targeting agents
11/01/2012US20120277162 Polypeptide compounds for inhibiting angiogenesis and tumor growth
11/01/2012US20120277161 Inhibition of multiple cell activation pathways
11/01/2012US20120277158 Compositions and methods for the transport of therapeutic agents
11/01/2012US20120277146 Compounds For Enzyme Inhibition
11/01/2012US20120277144 Novel compounds for modulating neovascularisation and methods of treatment using these compounds
11/01/2012US20120277143 IL4/IL13 Binding Repeat Proteins and Uses
11/01/2012US20120277142 Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof, and method for preparing same
11/01/2012US20120276215 Therapeutic Conditioned Media
11/01/2012US20120276212 Composition comprising plant and/or fish oils and non-oxidizable fatty acid entities
11/01/2012US20120276200 Formulations of quinolinones
11/01/2012US20120276192 Compositions and methods for sirna inhibition of icam-1
11/01/2012US20120276190 Therapy with a chimeric molecule and a pro-apoptotic agent
11/01/2012US20120276189 Therapeutic Treatment of Dermatologic Skin Disorders
11/01/2012US20120276171 Micelle encapsulation of therapeutic agents
11/01/2012US20120276170 Injectable drug carrier comprising layered double hydroxide
11/01/2012US20120276169 Polymer nanoparticle injection formulation composition containing rapamycin with improved water solubility, preparation method thereof, and anticancer composition for combined use with radiotherapy
11/01/2012US20120276163 Anti-cancer composition comprising alginate
11/01/2012US20120276162 Drug Loaded Polymeric Nanoparticles and Methods of Making and Using Same
11/01/2012US20120276151 Drug delivery from embolic agents
11/01/2012US20120276148 Adenoviral vector vaccine
11/01/2012US20120276147 Ctsp cancer-testis antigens
1 ... 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 ... 2211